Publications by authors named "Ashley Boam"

Claim this Profile
A
Antioxidants had No Effects on the In-Vitro Permeability of BCS III Model Drug Substances.
Dongmei Lu, Bhagwant Rege, Andre Raw, Jingyue Yang, Khondoker Alam, Ashley Boam

J Pharm Sci· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A network of regulatory innovations to improve FDA quality assessments of human drug applications.
Russie Tran, Grace Fraser, Adam C Fisher, Sau L Lee, Ashley Boam

Int J Pharm X· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An audit of pharmaceutical continuous manufacturing regulatory submissions and outcomes in the US.
Adam C Fisher, William Liu, Andreas Schick, Mahesh Ramanadham, Sharmista Chatterjee, Ashley B Boam

Int J Pharm· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing Product Quality: a Summary of the Second FDA/PQRI Conference.
Lawrence X Yu, Ilgaz Akseli, Barbara Allen, Gregory Amidon, Tara Gooen Bizjak, Ashley Boam

AAPS J· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing Product Quality: a Summary of the Inaugural FDA/PQRI Conference.
Lawrence X Yu, Jeffrey Baker, Susan C Berlam, Ashley Boam, E J Brandreth

AAPS J· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The academic research consortium governance charter.
Mitchell W Krucoff, Roxana Mehran, Gerrit-Anne van Es, Ashley B Boam, Donald E Cutlip

JACC Cardiovasc Interv· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percutaneous coronary intervention in perspective: drug-eluting stents as a model for regulatory review.
David E Kandzari, Andrew Farb, Ashley B Boam

Circ Cardiovasc Interv· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-eluting stents "deliver heartburn": how do we spell relief going forward?
Mitchell W Krucoff, Ashley Boam, Daniel G Schultz

Circulation· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical end points in coronary stent trials: a case for standardized definitions.
Donald E Cutlip, Stephan Windecker, Roxana Mehran, Ashley Boam, David J Cohen

Circulation· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stent thrombosis redux--the FDA perspective.
Andrew Farb, Ashley B Boam

N Engl J Med· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory issues facing the development of drug-eluting stents: a US FDA perspective.
Ashley B Boam

Expert Rev Med Devices· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in regulating breakthrough medical devices.
Neal I Muni, Thomas P Gross, Ashley B Boam, Stanley Wang, Bram D Zuckerman

Food Drug Law J· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coronary drug-eluting stent development: issues in trial design.
Neal I Muni, Robert M Califf, Jonette R Foy, Ashley B Boam, Bram D Zuckerman

Am Heart J· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective evaluation of intraocular lenses in adults younger than 60 years.
Ashley B Boam, Malvina B Eydelman, Flora C Lum, Phyllis M Silverman, David J Apple

J Cataract Refract Surg· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis